Hepatomas in young women on oral contraceptives: Report of two cases and review of the literature
- 1 January 1983
- journal article
- case report
- Published by Wiley in Journal of Surgical Oncology
- Vol. 22 (1) , 11-14
- https://doi.org/10.1002/jso.2930220105
Abstract
Hepatocellular carcinoma (HCC) developed in two women who had ingested oral contraceptives for prolonged duration. One of the patients had hepatoma restricted to the liver, and it was successfully resected. The other patient presented with metastatic HCC to the sacrum and lung, and she died after an initial response to chemotherapy in 12 months. Review of literature showed 23 previously reported cases of HCC associated with “pill” use since 1973. Although the reported instances of HCC in pill users are few in number, the majority of affected females were in their 20s and early 30s, without any preexisting liver disease. Even though the risk of developing HCC on oral contraceptives is low, this association adds to the list of complications induced by oral contraceptives in premenopausal women. Two cases are reported and literature reviewed.Keywords
This publication has 11 references indexed in Scilit:
- ORAL-CONTRACEPTIVE-ASSOCIATED LIVER TUMOURS: OCCURRENCE OF MALIGNANCY AND DIFFICULTIES IN DIAGNOSISThe Lancet, 1980
- HEPATOCARCINOMA AND ORAL CONTRACEPTIVESThe Lancet, 1978
- Hepatocellular carcinoma in a woman on long-term oral contraceptivesCancer, 1977
- ORAL CONTRACEPTIVES AND MALIGNANT HEPATOMAThe Lancet, 1976
- Oral Contraceptives and Malignant Hepatic TumoursThe Lancet, 1976
- Hepatic Changes in Young Women Ingesting Contraceptive SteroidsPublished by American Medical Association (AMA) ,1976
- Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.BMJ, 1975
- HEPATOBLASTOMA ASSOCIATED WITH AN ORAL CONTRACEPTIVEThe Lancet, 1974
- HEPATOMAS AND ORAL CONTRACEPTIVESThe Lancet, 1974
- LIVER-CELL CARCINOMA AFTER LONG-TERM ŒSTROGEN-LIKE DRUGSThe Lancet, 1974